Task B4 · evidence aggregation
In which hematologic malignancies does the corpus describe TP53 status as prognostically significant, and for which is a specific patient population or predictive role noted?
Gold evidence
Acceptable answer concepts
- childhood acute lymphoblastic leukemia (ALL)
- multiple myeloma
- biallelic TP53 lesions are among the most powerful predictors of high-risk disease in multiple myeloma
Construction note
PMID:31897170 studies TP53 mRNA prognostic value in childhood ALL; PMID:31792264 states TP53 lesions affecting both gene copies are among the most powerful predictors of high-risk multiple myeloma.
How each architecture answered
Baseline 0 · no retrieval
Yuu no Sekai · 523 tokens · 4.0s(abstained) No evidence passages were retrieved to answer the question regarding the prognostic significance of TP53 status in hematologic malignancies or its specific patient population or predictive role.
The corpus does not provide information on hematologic malignancies where TP53 status is described as prognostically significant.
The corpus does not specify any patient population or predictive role associated with TP53 status in hematologic malignancies.
Baseline 1 · retrieve + synthesize
Yuu no Sekai · 2244 tokens · 5.5s(abstained) The provided evidence does not describe TP53 status as prognostically significant in any hematologic malignancies. Additionally, there is no mention of a specific patient population or predictive role for TP53.
TP53 status is not described as prognostically significant in any hematologic malignancies in the provided evidence.
The provided evidence does not mention a specific patient population or predictive role for TP53.
Agent 1 · planner + retrieve + synthesize
Yuu no Sekai · 2771 tokens · 9.7sThe corpus describes TP53 status as prognostically significant in childhood acute lymphoblastic leukemia (ALL) and multiple myeloma (MM). In childhood ALL, high TP53 expression is associated with poor overall survival (OS) and relapse-free survival (RFS), serving as an independent prognostic factor. In MM, lesions affecting both copies of the TP53 gene are strong predictors of high-risk disease.
High TP53 expression is associated with poor outcomes in childhood acute lymphoblastic leukemia (ALL).
TP53 status is a prognostic marker in childhood acute lymphoblastic leukemia (ALL).
TP53 status is prognostically significant in multiple myeloma (MM).
TP53 status is a predictor for high-risk disease in multiple myeloma (MM).